Research & Development
Browse our research documents and publications, view our product pipeline and learn more about our research partners.
Reports, publications, and papers
Browse relevant documents to see the insights and thought leadership that we’ve spear headed over the years.
Patient Voices Podcast Episode 1 – Katy Pieris
Welcome to Patient Voices by Ampersand Health. We want to champion the experiences and opinions of the most important members of the healthcare ecosystem,...
Patient Voices Podcast Launch – August 2021
My IBD Care Service Evaluation at King’s College Hospital & The Royal London
On Demand Webinar – Digital Therapeutics: Transforming Patient Experience and Quality of Life
Clinician-Patient Communication: Time for a Wake-up Call?
In light of the launch of My Arthritis, Ampersand Health hosted an industry roundtable to discuss the future of clinician-patient communication.
My Arthritis App: Q&A for Clinicians
We answer common questions that clinicians may have around the application and benefits of our My Arthritis app.
Ampersand Health launches Whitepaper: Designing Digital Behaviour Change Interventions
The paper uncovers the evidence behind our digital therapeutics approach to managing immune-mediated inflammatory conditions (IMIDs) such as Inflammatory Bowel...
The Approach to Effectiveness Evaluation and User-Centred Design
Comments from leading digital health apps at HETT 2019. In January 2019, the NHS Long Term Plan was released and Chapter 4 read ‘Digitally-enabled care will...
NRAS and Ampersand Health Partner to Launch Innovative App to Help People with Rheumatoid Arthritis
My Arthritis empowers patients with timely, relevant information and is designed to improve quality of life and outcomes.
Digital therapeutics: A step change for health and wellbeing
We have recently been featured in an article on PWC's tackling the importance of patient-centric digital health interventions.
Our HealthSuite can help manage a range of inflammatory conditions
Our research and development focuses on the full breadth of inflammatory and immuno-mediated conditions, enabling us to build an exciting roadmap of digital medicines.
Currently, an observational trial is underway that is looking into the effectiveness of using a mobile application to collect Patient Reported Outcome data of those receiving treatment for Neuroendocrine Tumours.
This study is being conducted by King's College Hospital, along with a national charity and a major pharmaceutical company. Individuals who live with Neuroendocrine Tumours live a lower quality of life due to their condition. We are exploring the role digital therapeutics could play to alleviate treatment burden and improve clinical coordination to help patients gain a better quality of life.
Sickle Cell Disease
A leading NHS Trust and The Health Foundation are researching how our My Blood app can improve the process of collecting information from patients to avoid unnecessary trips to the hospital.
The My Blood app helps patients recieve remote care and could alleviate treatment burden, leading to benefits for both clinicians and patients.
Our app content is co-created with leading experts from 2 London hospitals.
NHS - Barts Health & King's College Hospital
We are partnered with the NHS, the world’s largest public health provider.
Our partnership with the NHS has allowed us to perform significant research and gain invaluable insights into the conditions that we focus on.
We have partnered with national charities, such as Crohn’s and Colitis UK.
Our partnerships with national charities allow us to gain important insights into the experiences of the communities we work with.
Our platform has been assessed and approved by NICE, The National Institute for Health and Care Excellence.
Our innovation has been funded by competitive grants from Innovate UK.
Our platform is regulated by the Medicines and Healthcare Products Regulatory Agency.
Our app received the top rating by ORCHA, who are world leaders in health app evaluations.